These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 12552998

  • 1. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH, Cory JG.
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
    Cory AH, Cory JG.
    Anticancer Res; 2001; 21(6A):3807-11. PubMed ID: 11911251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
    Somerville L, Cory JG.
    Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
    [Abstract] [Full Text] [Related]

  • 6. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV, Wu GS, Omura S, el-Deiry WS.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):564-9. PubMed ID: 8878553
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
    Chen L, Smith L, Wang Z, Smith JB.
    Mol Pharmacol; 2003 Aug 14; 64(2):334-45. PubMed ID: 12869638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells.
    Hall JG, Cory AH, Hickerson DH, Cory JG.
    Anticancer Res; 2001 Aug 14; 21(1A):173-80. PubMed ID: 11299731
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R.
    Clin Cancer Res; 2003 Mar 14; 9(3):1145-54. PubMed ID: 12631620
    [Abstract] [Full Text] [Related]

  • 12. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 22; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Understanding interactions between and among apoptosis inducing pathways in tumor cells.
    Cory AH, Cory JG.
    In Vivo; 2007 Apr 22; 21(2):245-9. PubMed ID: 17436572
    [Abstract] [Full Text] [Related]

  • 17. Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: necrosis vs. apoptosis.
    Cory AH, Chen J, Cory JG.
    Anticancer Res; 2006 Apr 22; 26(2A):1289-95. PubMed ID: 16619536
    [Abstract] [Full Text] [Related]

  • 18. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
    Chen F, Chang D, Goh M, Klibanov SA, Ljungman M.
    Cell Growth Differ; 2000 May 22; 11(5):239-46. PubMed ID: 10845424
    [Abstract] [Full Text] [Related]

  • 19. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N, Honda Y, Nakamura H, Fujiwara T, Tanaka K, Omura S, Shimbara N, Ogawa M, Saya H, Nakao M.
    Int J Mol Med; 1999 Feb 22; 3(2):127-37. PubMed ID: 9917519
    [Abstract] [Full Text] [Related]

  • 20. Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin.
    Park BS, Baek SJ, Song KH, Kim KH, Jeong SJ, Jeong MH, Seo SY, Lee SW, Yoo KS, Yoo YH.
    Nutr Cancer; 2002 Feb 22; 42(2):248-55. PubMed ID: 12416267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.